- Home
- CLPS vs GDTC Comparison
CLPS vs GDTC Comparison
Compare CLPS & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPS
- GDTC
- Stock Information
- Founded
- CLPS 2005
- GDTC 2018
- Country
- CLPS Hong Kong
- GDTC Singapore
- Employees
- CLPS N/A
- GDTC N/A
- Industry
- CLPS Computer Software: Prepackaged Software
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- CLPS Technology
- GDTC Health Care
- Exchange
- CLPS Nasdaq
- GDTC Nasdaq
- Market Cap
- CLPS 26.6M
- GDTC 28.0M
- IPO Year
- CLPS 2018
- GDTC 2023
- Fundamental
- Price
- CLPS $0.95
- GDTC $1.90
- Analyst Decision
- CLPS
- GDTC Buy
- Analyst Count
- CLPS 0
- GDTC 1
- Target Price
- CLPS N/A
- GDTC $5.00
- AVG Volume (30 Days)
- CLPS 10.8K
- GDTC 15.1K
- Earning Date
- CLPS 03-05-2025
- GDTC 01-01-0001
- Dividend Yield
- CLPS 13.54%
- GDTC N/A
- EPS Growth
- CLPS N/A
- GDTC N/A
- EPS
- CLPS N/A
- GDTC N/A
- Revenue
- CLPS $153,816,045.00
- GDTC $368,838.00
- Revenue This Year
- CLPS N/A
- GDTC $5.37
- Revenue Next Year
- CLPS N/A
- GDTC N/A
- P/E Ratio
- CLPS N/A
- GDTC N/A
- Revenue Growth
- CLPS 5.81
- GDTC N/A
- 52 Week Low
- CLPS $0.68
- GDTC $1.20
- 52 Week High
- CLPS $1.70
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- CLPS 46.68
- GDTC 34.50
- Support Level
- CLPS $0.94
- GDTC $1.75
- Resistance Level
- CLPS $1.03
- GDTC $2.26
- Average True Range (ATR)
- CLPS 0.05
- GDTC 0.13
- MACD
- CLPS 0.00
- GDTC -0.03
- Stochastic Oscillator
- CLPS 38.46
- GDTC 25.00
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.